{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:02:32Z","timestamp":1784862152996,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-026-04398-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:47:28Z","timestamp":1784861248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of 5-aminolevulinic acid\u2013guided surgery versus white-light resection in newly diagnosed glioblastoma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9323-8243","authenticated-orcid":false,"given":"Ahmed","family":"Mueed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouraiz","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Ahsun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainat","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"4","key":"4398_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040856","volume":"13","author":"HM Nguyen","year":"2021","unstructured":"Nguyen HM, Guz-Montgomery K, Lowe DB, Saha D (2021) Pathogenetic features and current management of glioblastoma. Cancers (Basel) 13(4):856","journal-title":"Cancers (Basel)"},{"key":"#cr-split#-4398_CR2.1","unstructured":"Tamimi AF, Juweid M (2017) Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma. Brisbane (AU): Codon Publications"},{"key":"#cr-split#-4398_CR2.2","unstructured":"[cited 2025 Nov 9]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470003\/"},{"issue":"6","key":"4398_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1517\/14728220902942348","volume":"13","author":"OO Kanu","year":"2009","unstructured":"Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD et al (2009) Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets 13(6):701\u2013718","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"4398_CR4","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s13311-022-01320-w","volume":"19","author":"Y Yang","year":"2022","unstructured":"Yang Y, Schubert MC, Kuner T, Wick W, Winkler F, Venkataramani V (2022) Brain tumor networks in diffuse glioma. Neurotherapeutics 19(6):1832\u20131843","journal-title":"Neurotherapeutics"},{"issue":"2","key":"4398_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0517-x","volume":"15","author":"JP Almeida","year":"2015","unstructured":"Almeida JP, Chaichana KL, Rincon-Torroella J, Quinones-Hinojosa A (2015) The value of extent of resection of glioblastomas: clinical evidence and current approach. Curr Neurol Neurosci Rep 15(2):517","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"4398_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1227\/NEU.0000000000000929","volume":"77","author":"CG Hadjipanayis","year":"2015","unstructured":"Hadjipanayis CG, Widhalm G, Stummer W (2015) What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery 77(5):663\u2013673","journal-title":"Neurosurgery"},{"issue":"1","key":"4398_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1227\/NEU.0000000000000344","volume":"75","author":"JTC Liu","year":"2014","unstructured":"Liu JTC, Meza D, Sanai N (2014) Trends in fluorescence image-guided surgery for gliomas. Neurosurgery 75(1):61\u201371","journal-title":"Neurosurgery"},{"issue":"5","key":"4398_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392\u2013401","journal-title":"Lancet Oncol"},{"issue":"4","key":"4398_CR9","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3171\/2023.7.JNS231170","volume":"140","author":"T Picart","year":"2024","unstructured":"Picart T, Pallud J, Berthiller J, Dumot C, Berhouma M, Ducray F et al (2024) Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study. J Neurosurg 140(4):987\u20131000","journal-title":"J Neurosurg"},{"issue":"1","key":"4398_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.26444\/aaem\/194075","volume":"32","author":"M Mazurek","year":"2025","unstructured":"Mazurek M, Lehman N, Stoma F, Czaja G, Banach A, Jarosz B et al (2025) How 5-ALA enlightens neurosurgery - results of a single centre study on high-grade gliomas. Ann Agric Environ Med 32(1):133\u2013141","journal-title":"Ann Agric Environ Med"},{"issue":"12","key":"4398_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17121897","volume":"17","author":"N Ryskeldiyev","year":"2025","unstructured":"Ryskeldiyev N, Moldabekov A, Berdibayeva D, Maidan A, Tursynbekov T, Davletov D et al (2025) Comparative analysis of clinical outcomes in high-grade glioma patients: 5-ALA fluorescence-guided surgery vs. conventional white-light resection. Cancers (Basel) 17(12):1897","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4398_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/nop\/npu011","volume":"1","author":"SK Kim","year":"2014","unstructured":"Kim SK, Choi SH, Kim YH, Park CK (2014) Impact of fluorescence-guided surgery on the improvement of clinical outcomes in glioblastoma patients. Neuro-oncol Pract 1(3):81\u201385","journal-title":"Neuro-oncol Pract"},{"issue":"2","key":"4398_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21315\/mjms2017.24.2.10","volume":"24","author":"WP Ng","year":"2017","unstructured":"Ng WP, Liew BS, Idris Z, Rosman AK (2017) Fluorescence-guided versus conventional surgical resection of high grade glioma: a single-centre, 7-year, comparative effectiveness study. Malays J Med Sci 24(2):78\u201386","journal-title":"Malays J Med Sci"},{"issue":"7","key":"4398_CR14","volume":"15","author":"LS Wong","year":"2023","unstructured":"Wong LS, St George J, Agyemang K, Grivas A, Houston D, Foo SY et al (2023) Outcomes of fluorescence-guided vs white light resection of glioblastoma in a single institution. Cureus 15(7):e42695","journal-title":"Cureus"},{"issue":"5","key":"4398_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/lsm.22359","volume":"47","author":"HA Leroy","year":"2015","unstructured":"Leroy HA, Vermandel M, Lejeune JP, Mordon S, Reyns N (2015) Fluorescence guided resection and glioblastoma in 2015: a review. Lasers Surg Med 47(5):441\u2013451","journal-title":"Lasers Surg Med"},{"key":"4398_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00620","volume":"9","author":"S Gandhi","year":"2019","unstructured":"Gandhi S, Tayebi Meybodi A, Belykh E, Cavallo C, Zhao X, Syed MP et al (2019) Survival outcomes among patients with high-grade glioma treated with 5-aminolevulinic acid-guided surgery: a systematic review and meta-analysis. Front Oncol 9:620","journal-title":"Front Oncol"},{"key":"4398_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"10","key":"4398_CR18","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev 10(10):ED000142","journal-title":"Cochrane Database Syst Rev"},{"key":"4398_CR19","doi-asserted-by":"crossref","unstructured":"Van der Wees P, Qaseem A, Kaila M, Ollenschlaeger G, Rosenfeld R (2012) Board of Trustees of the Guidelines International Network (G-I-N). Prospective systematic review registration: perspective from the Guidelines International Network (G-I-N). Syst Rev 1:3","DOI":"10.1186\/2046-4053-1-3"},{"issue":"7414","key":"4398_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"1","key":"4398_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-4-38","volume":"4","author":"D Atkins","year":"2004","unstructured":"Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S et al (2004) Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 4(1):38","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"4398_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1378\/chest.129.1.174","volume":"129","author":"G Guyatt","year":"2006","unstructured":"Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest 129(1):174\u2013181","journal-title":"Chest"},{"issue":"2","key":"4398_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190\u2013198","journal-title":"J Neurosurg"},{"issue":"6","key":"4398_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1215\/15228517-2008-052","volume":"10","author":"U Pichlmeier","year":"2008","unstructured":"Pichlmeier U, Bink A, Schackert G, Stummer W, ALA Glioma Study Group (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025\u20131034","journal-title":"Neuro Oncol"},{"issue":"10","key":"4398_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.neurol.2011.07.004","volume":"167","author":"N Sanai","year":"2011","unstructured":"Sanai N, Berger MS (2011) Extent of resection influences outcomes for patients with gliomas. Rev Neurol (Paris) 167(10):648\u2013654","journal-title":"Rev Neurol (Paris)"},{"issue":"8","key":"4398_CR26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1200\/JCO.2007.13.9337","volume":"26","author":"JS Smith","year":"2008","unstructured":"Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S et al (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26(8):1338\u20131345","journal-title":"J Clin Oncol"},{"issue":"10","key":"4398_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"3","key":"4398_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3171\/2010.2.JNS091322","volume":"114","author":"DW Roberts","year":"2011","unstructured":"Roberts DW, Vald\u00e9s PA, Harris BT, Fontaine KM, Hartov A, Fan X et al (2011) Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between \u03b4-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg 114(3):595\u2013603","journal-title":"J Neurosurg"},{"issue":"2","key":"4398_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3171\/2009.10.JNS09447","volume":"113","author":"GC Feigl","year":"2010","unstructured":"Feigl GC, Ritz R, Moraes M, Klein J, Ramina K, Gharabaghi A et al (2010) Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg 113(2):352\u2013357","journal-title":"J Neurosurg"},{"issue":"5","key":"4398_CR30","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.3390\/ijms160510443","volume":"16","author":"S Eljamel","year":"2015","unstructured":"Eljamel S (2015) 5-ALA fluorescence image guided resection of glioblastoma multiforme: a meta-analysis of the literature. Int J Mol Sci 16(5):10443\u201310456","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4398_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3171\/2011.2.JNS101451","volume":"115","author":"PA Vald\u00e9s","year":"2011","unstructured":"Vald\u00e9s PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X et al (2011) Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115(1):11\u201317","journal-title":"J Neurosurg"},{"issue":"1","key":"4398_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3171\/2019.1.JNS182614","volume":"133","author":"G Widhalm","year":"2020","unstructured":"Widhalm G, Olson J, Weller J, Bravo J, Han SJ, Phillips J et al (2020) The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas. J Neurosurg 133(1):79\u201388","journal-title":"J Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-026-04398-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:47:30Z","timestamp":1784861250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-026-04398-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4398"],"URL":"https:\/\/doi.org\/10.1007\/s10143-026-04398-4","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study does not involve human participants. Ethical approval was not required for this systematic review, since all data came from published articles.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Patient consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"492"}}